MedScout
A revenue acceleration platform for MedTech commercial teams
A revenue acceleration platform for MedTech commercial teams
MedScout is a MedTech startup that offers a revenue acceleration platform for MedTech commercial teams. The company was founded in 2021 and is headquartered in the United States.
The platform leverages the latest healthcare claims data to provide actionable insights for sales representatives, ultimately enabling a more focused and efficient sales cycle. MedScout's proprietary dataset incorporates claims from Medicare and Commercial payers, covering over 310 million unique patients in the United States. Notably, the platform is updated monthly to ensure that the data remains fresh.
By translating over 34 billion raw claims into clear, actionable insights, MedScout empowers sales teams to identify and prioritize opportunities at every stage of the commercial cycle. What sets MedScout apart is its focus on intuitiveness; the platform is intentionally designed to be accessible for the entire team, ensuring that the valuable data can be effectively utilized by the sales representatives. Customers have described MedScout as the "Easy Button for Sales."
The startup recently secured a $5.00M in a Seed Round investment on 27 June 2023. The investment was led by prominent venture capital firms including LiveOak Venture Partners, Stage 2 Capital, Andreessen Horowitz (a16z), and Alumni Ventures Blockchain Fund.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $15.00M | 3 |
|
26 Jul 2024 |
| Seed Round | $5.00M | 4 |
|
27 Jun 2023 |
| Pre Seed Round | $800.00K | 3 | Luke Fernandez, Mario Feghali +1 | 09 Jun 2021 |
No recent news or press coverage available for MedScout.
We care about your data, and we'd love to use cookies make your experience better.
